LRP6 and metabolic syndrome: For instance, a missense mutation (R611C) in human LRP6 that results in a change of a highly conserved residue in the EGF domain has been identified as the cause of autosomal dominant early onset CAD and metabolic syndrome traits, including hyperlipidemia, type 2 diabetes, osteoporosis, and hypertension [3].